Growth of Lung Tumors Reduced

by Jeffil Obadiah on  January 27, 2020 at 10:06 AM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

Scientists have discovered a revolutionary drug that inhibits the growth of lung tumors.
Growth of Lung Tumors Reduced
Growth of Lung Tumors Reduced

In 2018, 1.7 million people died from lung cancer worldwide, a number equivalent to the population of Barcelona. The high mortality rate of lung cancer reflects the need for the development of treatments that are more efficient.

Show Full Article


A study headed by Ángel R. Nebreda, ICREA researcher and head of the Signalling and Cell Cycle Lab at the Institute for Research in Biomedicine (IRB Barcelona) and published in the journal PNAS demonstrates that the protein p38 is one of the key elements supporting lung cancer growth.

In particular, the study focuses on cells expressing the oncogene Kras, which causes the transformation of a healthy cell into a cancer cell and whose mutations are responsible for approximately 25% of lung cancer cases.

For this study, scientists have used genetic mouse models that develop lung tumors with the KrasG12V mutation. Using these models, they have observed that p38 inhibition leads to a dramatic reduction in tumor growth and aggressiveness.

Furthermore, complementary studies performed with information deposited in cancer genome databases indicate that the patients with lower levels of p38 in tumors have a more favorable prognosis. This function of p38 is related to the production of factors that stimulate cancer cell division and thus enhance tumour growth.

The relevance of this work lies in the fact that "it shows how tumours exploit a protein, which in principle protects healthy lung cells, for their own progression," says Jessica Vitos, first author of the paper. The result of this study may find therapeutic application. In this regard, "Chemical compounds that inhibit p38 function would interfere with the growth of lung cancer cells," she explains.

The study has been funded by the European Research Council (ERC), the Spanish Ministry of Science, Innovation and Universities (MICINN), the Catalonian Agency for Management of University and Research Grants (AGAUR), and the BBVA Foundation.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive